Bioengineered Protein Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024
Global Bioengineered Protein Drugs Market: By Drug Type (Vaccines, Peptide hormones, Blood Products, Monoclonal antibodies, Recombinant protein drugs, Replacement proteins, Peptide antibiotics, Therapeutic enzymes, Cytokines), By Technology (Bioreactors and microbial cell fermentation, Genetically modified organisms, Fractionation, Pharming, Others), By Application (Diabetes, Heart diseases, Neurodegenerative diseases, Respiratory diseases, Infectious diseases, Congenital diseases, Others), By Drug delivery (Traditional methods, Novel Methods), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global bioengineered protein drugs market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024

Market Outline: Bioengineered Protein Drugs Market
Bioengineered proteins are formulated as the fundamental participants in the biological process. They are target specific and have lesser side effects which leads to higher acceptance when compared to that of a small molecule. The bioengineered proteins act as the powerful therapeutic agents. They include a wide range of products such as monoclonal antibodies, cytokines, growth factors, and many. Due to various factors such as bio-reactivity, safety, and success rate bioengineered proteins are gaining popularity all across the healthcare industry.

Market Dynamics: Bioengineered Protein Drugs Market
Increase in prevalence of chronic diseases such as diabetics, cancer etc. is one of the major factor responsible for the growth of the bioengineered protein drugs market. According to the WHO, the diabetic population is expected to grow by 366 million by 2030. The technological advancements in the drug delivery system and noticeable manufacturing developments in the biopharmaceutical industry is likely to drive the growth of the bioengineered protein drugs market over the forecast period. The minimal side effects of the bioengineered protein drugs also boosting the growth of the market. However, the higher cost of the drugs is likely to hamper the growth of the market.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/bioengineered-protein-drugs-market/#ulp-4H8Z4LpNMLEuOnnx

Market Scope: Bioengineered Protein Drugs Market
Bioengineered protein drugs market is segmented on the basis of drug type, technology, application, and by drug delivery.
Based on the drug type, the market is segmented into the following:
• Vaccines
o Subunit/Conjugate
o Toxoid
o Live Attenuated Vaccines
o Inactivated/Killed Vaccines
• Peptide Hormones
o Growth Hormones
o Erythropoietin
o Insulin
o Luteinizing Hormones
o Follicle Stimulating Hormones
• Blood Products
o Coagulation Factors
o Thrombin
o Immune Globulins
o C1 Esterase Inhibitor
o Alpha 1-Protease Inhibitor
o Antithrombin
• Monoclonal Antibodies
• Recombinant Protein Drugs
• Replacement Proteins
• Peptide Antibiotics
• Therapeutic Enzymes
o Metabolic Enzymes
o Digestive Enzymes
o Others
• Cytokines
o Interferons
o Interleukins
o Colony stimulating factors
Based on the technology, the market is segmented into the following:
• Bioreactors and Microbial Cell Fermentation
• Genetically Modified Organisms
• Fractionation
• Pharming
• Others
Based on the application, the market is segmented into the following:
• Diabetes
• Heart Diseases
• Neurodegenerative Diseases
• Respiratory Diseases
• Infectious Diseases
• Congenital Diseases
• Others
Based on the drug delivery, the market is segmented into the following:
• Traditional methods
• Novel Methods

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/bioengineered-protein-drugs-market/#ulp-c654SbFYO64MsOhu

Regional Analysis: Bioengineered Protein Drugs Market
Geographically, global bioengineered protein drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America bioengineered protein drugs market holding larger revenue share when compared with that of the other markets. The growing technological advanced products, developed research sector are driving the growth of the bioengineered protein drugs market in North America region. The growing awareness among the people about chronic diseases and the higher adoption of the new drugs is also responsible for the growth of the market in this region. The Asia Pacific region expected to grow at significant rate owing to expansion of the biopharmaceutical industries in the region. The developing economic scenario is showing scope for the development of R&D activities in this region.

Competition Assessment: Bioengineered Protein Drugs Market
Some of the players in the global bioengineered protein drugs market include:
• Abbott Laboratories (U.S)
• Amgen (U.S)
• KEDRION BIOPHARMA (U.S)
• Merck & Co., Inc. (U.S)
• Allergan (Ireland)
• Eli Lilly and Company (U.S)
• Johnson & Johnson (U.S)
• Panacea Biotec (India)
• GlaxoSmithKline plc (U.K)
• Hoffmann-La Roche (Switzerland)

Notable Market Developments: Bioengineered Protein Drugs Market
• In August 2017, Kedrion Biopharma and Kamada Ltd. has received U.S. Food and Drug Administration (FDA) approval for KEDRAB™ [rabies immune globulin (Human)], for passive, transient post-exposure prophylaxis of rabies infection, when given immediately after contact with a rabid or possibly rabid animal.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/bioengineered-protein-drugs-market/#ulp-14mlyhjMGhVjZqa3

Key Features of the Report:
• The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
• The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/bioengineered-protein-drugs-market/
About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX

Email: [email protected]

Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com